Y-Intercept (HK)’s Cymabay Therapeutics CBAY Stock Holding History

Y-Intercept (HK)’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,924	Closed	-$353K	–	1848
2023 Q4	$353K	Buy	+14,924	New	+$266K	0.03%	762
2022 Q3	–	Sell	-23,644	Closed	-$70K	–	1354
2022 Q2	$70K	Buy	+23,644	New	+$56.5K	0.01%	738

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Y-Intercept (HK)'s CBAY Position: Q1 2024 in Review

Y-Intercept (HK) sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 14,924 shares — an estimated $353K sold.

Y-Intercept (HK) first reported a position in CBAY in Q2 2022 and held it in 2 quarters. The position peaked at $353K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Y-Intercept (HK) reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Y-Intercept (HK) sold 14,924 Cymabay Therapeutics shares in Q1 2024, an estimated $353K.
Y-Intercept (HK) first reported a position in Cymabay Therapeutics in Q2 2022 and held it in 2 quarters.
Y-Intercept (HK)'s Cymabay Therapeutics position peaked at $353K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Y-Intercept (HK)'s 13F filing for Q1 2024, filed 10 May 2024.